We are live on ! Find out more
NVRO

NEVRO CORP.
NVRO

Delisted

NVRO was delisted on the 2nd of April, 2025.

Back to rankings

210 hedge funds and large institutions have $4.98B invested in NEVRO CORP. in 2020 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 79 increasing their positions, 77 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 26

12% more capital invested

Capital invested by funds: $4.45B → $4.98B (+$530M)

4% more funds holding

Funds holding: 202 → 210 (+8)

3% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 77

0% more call options, than puts

Call options by funds: $34.4M | Put options by funds: $34.2M

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
210
Holders Change
+8
Holders Change %
+3.96%
% of All Funds
4.24%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.06%
New
34
Increased
79
Reduced
77
Closed
26
Calls
$34.4M
Puts
$34.2M
Net Calls
+$160K
Net Calls Change
+$11.1M

Top Buyers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
+$28.6M
2
Jennison Associates
Jennison Associates
New York
+$28M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$19.7M
4
Millennium Management
Millennium Management
New York
+$18.3M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$16.9M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$68.7M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$44.3M
3
HM
HealthCor Management
New York
-$43.2M
4
Renaissance Technologies
Renaissance Technologies
New York
-$21.4M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$18.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Aviva
101
Aviva
United Kingdom
$2.2M -$474K -3,548 -18%
HighTower Advisors
102
HighTower Advisors
Illinois
$2.18M +$363K +2,716 +21%
State Board of Administration of Florida Retirement System
103
State Board of Administration of Florida Retirement System
Florida
$2.04M +$93.5K +700 +5%
FP
104
Foundry Partners
Minnesota
$2.04M +$169K +1,262 +9%
OAM
105
Oppenheimer Asset Management
New York
$2.01M +$204K +1,528 +12%
UCFA
106
United Capital Financial Advisors
Texas
$1.96M – – –
MIM
107
MetLife Investment Management
New Jersey
$1.96M -$96.3K -721 -5%
PMAM
108
Picton Mahoney Asset Management
Ontario, Canada
$1.93M -$86K -644 -4%
Calamos Advisors
109
Calamos Advisors
Illinois
$1.86M +$1.78M +13,352 New
Envestnet Asset Management
110
Envestnet Asset Management
Illinois
$1.79M +$97.1K +727 +6%
Prudential Financial
111
Prudential Financial
New Jersey
$1.75M +$1.3M +9,767 +352%
EFEM
112
Eos Focused Equity Management
New York
$1.69M +$1.62M +12,098 New
SCM
113
Soleus Capital Management
Connecticut
$1.66M -$918K -6,874 -37%
SO
114
STRS Ohio
Ohio
$1.63M -$53.4K -400 -3%
SG Americas Securities
115
SG Americas Securities
New York
$1.54M -$57.6K -431 -4%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
116
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$1.53M – – –
Los Angeles Capital Management
117
Los Angeles Capital Management
California
$1.5M – – –
PP
118
Paloma Partners
Connecticut
$1.38M +$890K +6,663 +206%
ASRS
119
Arizona State Retirement System
Arizona
$1.36M +$390K +2,922 +43%
MLICM
120
Metropolitan Life Insurance Company (MetLife)
New York
$1.35M -$66.7K -499 -5%
FIA
121
FNY Investment Advisers
New York
$1.25M +$468K +3,500 +64%
Comerica Bank
122
Comerica Bank
Texas
$1.24M -$13.4K -100 -1%
VRS
123
Virginia Retirement Systems
Virginia
$1.17M +$508K +3,800 +83%
DCM
124
Dupont Capital Management
Delaware
$1.16M +$1.11M +8,295 New
LCM
125
Landscape Capital Management
New Jersey
$1.14M +$1.09M +8,157 New
3 4
5
6 7

NVRO Hedge Fund Activity: Q3 2020 in Review

210 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q3 2020, worth a combined $4.98B — up 12% from $4.45B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new NVRO positions and 26 closed out — a net gain of 8 holders — while 79 added to existing stakes and 77 trimmed.

The largest buyer was PFM Health Sciences, adding an estimated $28.6M. The largest seller was Fidelity Investments, cutting an estimated $68.7M.

  • 210 institutional investors held NEVRO CORP. (NVRO) as of Q3 2020, up from 202 in Q2 2020.
  • Funds reported $4.98B of NEVRO CORP. stock for Q3 2020, up 12% quarter-over-quarter.
  • 34 funds opened new NEVRO CORP. positions in Q3 2020 and 26 closed out, a net change of +8 holders.
  • The largest NEVRO CORP. buyer in Q3 2020 was PFM Health Sciences, an estimated $28.6M added.
  • The largest NEVRO CORP. seller in Q3 2020 was Fidelity Investments, an estimated $68.7M sold.

Based on aggregated 13F filings for Q3 2020.